ZHONGHAIKANG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT

zhonghaikang-pharmaceutical-technology-development-logo

Zhonghaikang Pharmaceutical Technology Development is a drug research and development and drug promotion agency.

#SimilarOrganizations #More

ZHONGHAIKANG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT

Industry:
Medical Pharmaceutical Product Research

Founded:
2003-01-01

Address:
Beijing, Beijing, China

Country:
China

Status:
Active


Similar Organizations

alchemedicine-logo

Alchemedicine

Alchemedicine is a drug research and development company.

askat-logo

AskAt

AskAt is a pharmaceutical research and development firm that offers tech-based medical innovation and drug development solutions.

belx-biotechnology-logo

Belx Biotechnology

Belx Biotechnology is a research and development company.

crystal-genomics-logo

Crystal Genomics

Crystal Genomics is a drug research and development company.

twinpig-biolab-logo

Twinpig Biolab

Twinpig Biolab researches and develops anticancer drugs.

More informations about "Zhonghaikang Pharmaceutical Technology Development"

Zhonghaikang Pharmaceutical Technology Development

Zhonghaikang Pharmaceutical Technology Development is a drug research and development and drug promotion agency. ... Save . Summary. People. Signals & News. Similar Companies. …See details»

Zhonghaikang Pharmaceutical Technology Development

Zhonghaikang Pharmaceutical Technology Development is a drug research and development and drug promotion agency.See details»

Company News_ZSHK Laboratories Limited

On 28th November 2022 , ZSHK Laboratories Limited (ZSHK) announces its completion of nearly ï¿¥100 million series B financing. Such series of financing was led by AZ-CICC Healthcare …See details»

Beijing Zhonghaikang Pharm Tech Development Co. Ltd.

Explore Beijing Zhonghaikang Pharm Tech Development Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Meet the company on a mission to reengineer drug development

Dec 2, 2024 Drug development has a scarily high attrition rate, with approximately 90% of candidates falling short. R&D failure is particularly persistent in the oncology field, where …See details»

Beijing Zhonghaikang Pharmaceutical Technology Development …

Discovery Company profile page for Beijing Zhonghaikang Pharmaceutical Technology Development Co., Ltd. including technical research,competitor monitor,market trends,company …See details»

Out of the shadows: A brighter future for pharma technical …

Sep 16, 2022 Pharma technical development, also known as CMC (chemistry, manufacturing, and controls), is a complex multidisciplinary function critical to the successful development of …See details»

Pharmaceutical Industry Development: Key Policy Instruments in …

Feb 23, 2021 Abstract. The article provides an overview of programs, plans, tools of scientific and technological, innovation and industrial policy aimed at creating and producing new drugs …See details»

SK pharmteco announces $260m production expansion in South …

Sep 30, 2024 SK pharmteco, a contract development and manufacturing organisation, has announced an investment of $260m to expand its small molecule and peptide production …See details»

Cell and gene therapy approvals drive paradigm change in …

Oct 14, 2024 The number of contract manufacturing agreements for CGTs has been increasing in recent years, in line with increasing approvals and R&D in the CGT space. Up until now, …See details»

Beijing Zhonghui Huakang Pharmaceutical Technology …

100 Translational Medicine associated with Beijing Zhonghui Huakang Pharmaceutical Technology Development Co., Ltd. Login to view more data. Corporation Tree. Boost your …See details»

Benxi Economic Development Zone Zhonghaikang Pharmaceutical …

Explore Benxi Economic Development Zone Zhonghaikang Pharmaceutical Co with its drug pipeline, therapeutic area, technology platform, . Biomedical products DataSee details»

Pre-clinical CRO ZHSK Lab Nets Over CNY 100 Mn in Series B

Dec 1, 2022 Proceeds will be mainly used for the advancement of the construction of key resources needed for novel drugs and preclinical medical device evaluation and the business …See details»

The Evolution of High-Throughput Experimentation in …

May 7, 2019 High-throughput experimentation (HTE) has revolutionized the pharmaceutical industry, most notably allowing for rapid screening of compound libraries against therapeutic …See details»

How Does SAI Life Sciences Work? – CBM

4 days ago [cbm_blg_rlnkng]SAI Life Sciences is a leading research and development organization that specializes in delivering innovative solutions to the pharmaceutical and …See details»

Zai Lab and Pfizer to commercialise XACDURO in China

Nov 22, 2024 The World Health Organization included CRAB in the critical group category of its list of bacterial priority pathogens in 2024. Zai Lab chief operating officer and president Josh …See details»

Shenyang Zhonghaikang Pharmaceutical Technology Co., Ltd.

Last update 19 Sep 2024. Shenyang Zhonghaikang Pharmaceutical Technology Co., Ltd. Private Company |See details»

Driving the Future of Biopharma in 2025: How MoleculeAI is …

As the biotech industry embraces AI, MoleculeAI stands at the forefront, redefining drug discovery processes with cutting-edge technologies and collaborative efforts. In an interaction with …See details»

Generate and Novartis partner for protein therapeutics development

Sep 25, 2024 Novartis and Generate did not disclose the specific number of targets and therapeutic areas involved in the collaboration. Generate:Biomedicines CEO Mike Nally …See details»

linkstock.net © 2022. All rights reserved